Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.
The report details the trend, potential and market size of Blood Plasma Derivatives market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Blood Plasma Derivativesmarket, defines the market attractiveness level of Blood Plasma Derivatives market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Blood Plasma Derivatives industry, describes the types of Blood Plasma Derivatives market, the applications of major players and the market size, and deeply analyzes the current situation of the global Blood Plasma Derivatives market and the development prospects and opportunities of Blood Plasma Derivatives industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Blood Plasma Derivatives market in Chapter 13.
By Player:
Shire Plc
Fusion Health Care
Baxter International
Grifols
Kedrion Biopharma
Hualan Biological Engineering
Bayer AG
China Biologic Products
SK Plasma
BDI Pharma
Biotest AG
LFB
Green Cross Corporation
Octapharma AG
CSL Limited
By Type:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
By End-User:
Hospitals
Clinics
Other End Users
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Blood Plasma Derivatives Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Blood Plasma Derivatives Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Blood Plasma Derivatives Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Blood Plasma Derivatives Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Blood Plasma Derivatives Market Analysis and Outlook to 2022
-
7.1 Global Blood Plasma Derivatives Consumption (2017-2022)
-
7.2 United States Blood Plasma Derivatives Consumption (2017-2022)
-
7.3 Europe Blood Plasma Derivatives Consumption (2017-2022)
-
7.4 China Blood Plasma Derivatives Consumption (2017-2022)
-
7.5 Japan Blood Plasma Derivatives Consumption (2017-2022)
-
7.6 India Blood Plasma Derivatives Consumption (2017-2022)
-
7.7 South Korea Blood Plasma Derivatives Consumption (2017-2022)
8 Region and Country-wise Blood Plasma Derivatives Market Analysis and Outlook to 2028
-
8.1 Global Blood Plasma Derivatives Consumption Forecast (2022-2028)
-
8.2 United States Blood Plasma Derivatives Consumption Forecast (2022-2028)
-
8.3 Europe Blood Plasma Derivatives Consumption Forecast (2022-2028)
-
8.4 China Blood Plasma Derivatives Consumption Forecast (2022-2028)
-
8.5 Japan Blood Plasma Derivatives Consumption Forecast (2022-2028)
-
8.6 India Blood Plasma Derivatives Consumption Forecast (2022-2028)
-
8.7 South Korea Blood Plasma Derivatives Consumption Forecast (2022-2028)
9 Global Blood Plasma Derivatives Market Outlook by Types and Applications to 2022
-
9.1 Global Blood Plasma Derivatives Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Albumin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Factor VIII Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Factor IX Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Hyperimmune Globulin Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Blood Plasma Derivatives Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other End Users Consumption and Growth Rate (2017-2022)
10 Global Blood Plasma Derivatives Market Outlook by Types and Applications to 2028
-
10.1 Global Blood Plasma Derivatives Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Albumin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Factor IX Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Hyperimmune Globulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Blood Plasma Derivatives Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other End Users Consumption Forecast and Growth Rate (2022-2028)
11 Global Blood Plasma Derivatives Import and Export Analysis (Top 5 Countries)
-
11.1 Global Blood Plasma Derivatives Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Blood Plasma Derivatives Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Blood Plasma Derivatives Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Blood Plasma Derivatives Market Competitive Analysis
-
14.1 Shire Plc
-
14.1.1 Shire Plc Company Details
-
14.1.2 Shire Plc Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Shire Plc Blood Plasma Derivatives Product and Service
-
14.2 Fusion Health Care
-
14.2.1 Fusion Health Care Company Details
-
14.2.2 Fusion Health Care Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Fusion Health Care Blood Plasma Derivatives Product and Service
-
14.3 Baxter International
-
14.3.1 Baxter International Company Details
-
14.3.2 Baxter International Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Baxter International Blood Plasma Derivatives Product and Service
-
14.4 Grifols
-
14.4.1 Grifols Company Details
-
14.4.2 Grifols Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Grifols Blood Plasma Derivatives Product and Service
-
14.5 Kedrion Biopharma
-
14.5.1 Kedrion Biopharma Company Details
-
14.5.2 Kedrion Biopharma Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Kedrion Biopharma Blood Plasma Derivatives Product and Service
-
14.6 Hualan Biological Engineering
-
14.6.1 Hualan Biological Engineering Company Details
-
14.6.2 Hualan Biological Engineering Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Hualan Biological Engineering Blood Plasma Derivatives Product and Service
-
14.7 Bayer AG
-
14.7.1 Bayer AG Company Details
-
14.7.2 Bayer AG Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bayer AG Blood Plasma Derivatives Product and Service
-
14.8 China Biologic Products
-
14.8.1 China Biologic Products Company Details
-
14.8.2 China Biologic Products Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 China Biologic Products Blood Plasma Derivatives Product and Service
-
14.9 SK Plasma
-
14.9.1 SK Plasma Company Details
-
14.9.2 SK Plasma Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 SK Plasma Blood Plasma Derivatives Product and Service
-
14.10 BDI Pharma
-
14.10.1 BDI Pharma Company Details
-
14.10.2 BDI Pharma Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 BDI Pharma Blood Plasma Derivatives Product and Service
-
14.11 Biotest AG
-
14.11.1 Biotest AG Company Details
-
14.11.2 Biotest AG Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Biotest AG Blood Plasma Derivatives Product and Service
-
14.12 LFB
-
14.12.1 LFB Company Details
-
14.12.2 LFB Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 LFB Blood Plasma Derivatives Product and Service
-
14.13 Green Cross Corporation
-
14.13.1 Green Cross Corporation Company Details
-
14.13.2 Green Cross Corporation Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Green Cross Corporation Blood Plasma Derivatives Product and Service
-
14.14 Octapharma AG
-
14.14.1 Octapharma AG Company Details
-
14.14.2 Octapharma AG Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Octapharma AG Blood Plasma Derivatives Product and Service
-
14.15 CSL Limited
-
14.15.1 CSL Limited Company Details
-
14.15.2 CSL Limited Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 CSL Limited Blood Plasma Derivatives Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Blood Plasma Derivatives
-
Figure Blood Plasma Derivatives Picture
-
Table Global Blood Plasma Derivatives Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Blood Plasma Derivatives Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Blood Plasma Derivatives Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Blood Plasma Derivatives Consumption by Country (2017-2022)
-
Figure United States Blood Plasma Derivatives Consumption and Growth Rate (2017-2022)
-
Table Europe Blood Plasma Derivatives Consumption and Growth Rate (2017-2022)
-
Figure China Blood Plasma Derivatives Consumption and Growth Rate (2017-2022)
-
Figure Japan Blood Plasma Derivatives Consumption and Growth Rate (2017-2022)
-
Figure India Blood Plasma Derivatives Consumption and Growth Rate (2017-2022)
-
Figure South Korea Blood Plasma Derivatives Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Plasma Derivatives Consumption Forecast by Country (2022-2028)
-
Figure United States Blood Plasma Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Blood Plasma Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Blood Plasma Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Blood Plasma Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Blood Plasma Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Blood Plasma Derivatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Albumin Consumption and Growth Rate (2017-2022)
-
Figure Global Factor VIII Consumption and Growth Rate (2017-2022)
-
Figure Global Factor IX Consumption and Growth Rate (2017-2022)
-
Figure Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure Global Hyperimmune Globulin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Other End Users Consumption and Growth Rate (2017-2022)
-
Figure Global Albumin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Factor VIII Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Factor IX Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hyperimmune Globulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other End Users Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Blood Plasma Derivatives Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Blood Plasma Derivatives Export by Region (Top 5 Countries) (2017-2028)
-
Table Shire Plc (Foundation Year, Company Profile and etc.)
-
Table Shire Plc Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Plc Blood Plasma Derivatives Product and Service
-
Table Fusion Health Care (Foundation Year, Company Profile and etc.)
-
Table Fusion Health Care Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fusion Health Care Blood Plasma Derivatives Product and Service
-
Table Baxter International (Foundation Year, Company Profile and etc.)
-
Table Baxter International Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Blood Plasma Derivatives Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Blood Plasma Derivatives Product and Service
-
Table Kedrion Biopharma (Foundation Year, Company Profile and etc.)
-
Table Kedrion Biopharma Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Biopharma Blood Plasma Derivatives Product and Service
-
Table Hualan Biological Engineering (Foundation Year, Company Profile and etc.)
-
Table Hualan Biological Engineering Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hualan Biological Engineering Blood Plasma Derivatives Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Blood Plasma Derivatives Product and Service
-
Table China Biologic Products (Foundation Year, Company Profile and etc.)
-
Table China Biologic Products Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Biologic Products Blood Plasma Derivatives Product and Service
-
Table SK Plasma (Foundation Year, Company Profile and etc.)
-
Table SK Plasma Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table SK Plasma Blood Plasma Derivatives Product and Service
-
Table BDI Pharma (Foundation Year, Company Profile and etc.)
-
Table BDI Pharma Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table BDI Pharma Blood Plasma Derivatives Product and Service
-
Table Biotest AG (Foundation Year, Company Profile and etc.)
-
Table Biotest AG Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest AG Blood Plasma Derivatives Product and Service
-
Table LFB (Foundation Year, Company Profile and etc.)
-
Table LFB Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table LFB Blood Plasma Derivatives Product and Service
-
Table Green Cross Corporation (Foundation Year, Company Profile and etc.)
-
Table Green Cross Corporation Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Green Cross Corporation Blood Plasma Derivatives Product and Service
-
Table Octapharma AG (Foundation Year, Company Profile and etc.)
-
Table Octapharma AG Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma AG Blood Plasma Derivatives Product and Service
-
Table CSL Limited (Foundation Year, Company Profile and etc.)
-
Table CSL Limited Blood Plasma Derivatives Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Limited Blood Plasma Derivatives Product and Service
-
